US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist
  • 6.240
  • -0.100-1.58%
Close Nov 29 13:00 ET
  • 6.220
  • -0.020-0.32%
Post 14:15 ET
530.02MMarket Cap-5288P/E (TTM)

Terns Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-24.85%24.94M
20.69%25.54M
5.34%25.45M
65.34%102.56M
42.96%24.06M
91.90%33.18M
50.23%21.16M
74.73%24.16M
21.96%62.03M
13.11%16.83M
Selling and administrative expenses
-46.77%9.77M
2.53%7.19M
-3.41%6.86M
74.29%39.06M
6.95%6.6M
257.69%18.35M
29.25%7.01M
24.82%7.1M
14.65%22.41M
13.92%6.17M
-General and administrative expense
-46.77%9.77M
2.53%7.19M
-3.41%6.86M
74.29%39.06M
6.95%6.6M
257.69%18.35M
29.25%7.01M
24.82%7.1M
14.65%22.41M
13.92%6.17M
Research and development costs
2.28%15.17M
29.69%18.35M
8.98%18.59M
60.28%63.5M
63.81%17.46M
21.96%14.83M
63.37%14.15M
109.64%17.06M
26.53%39.62M
12.64%10.66M
Operating profit
24.85%-24.94M
-20.69%-25.54M
-5.34%-25.45M
-65.34%-102.56M
-42.96%-24.06M
-91.90%-33.18M
-50.23%-21.16M
-74.73%-24.16M
-24.41%-62.03M
-21.26%-16.83M
Net non-operating interest income expense
-11.26%3.09M
-15.29%2.88M
18.16%3.18M
511.42%12.9M
150.98%3.33M
597.39%3.48M
1,486.45%3.4M
3,802.90%2.69M
1,141.18%2.11M
2,314.55%1.33M
Non-operating interest income
-11.26%3.09M
-15.29%2.88M
18.16%3.18M
511.42%12.9M
150.98%3.33M
597.39%3.48M
1,486.45%3.4M
3,802.90%2.69M
1,141.18%2.11M
2,314.55%1.33M
Other net income (expense)
-540.00%-32K
76.67%-14K
-200.00%-12K
-361.76%-314K
-6,025.00%-245K
64.29%-5K
-11.11%-60K
-200.00%-4K
-270.00%-68K
-140.00%-4K
Other non- operating income (expenses)
-540.00%-32K
76.67%-14K
-200.00%-12K
-361.76%-314K
-6,025.00%-245K
64.29%-5K
-11.11%-60K
-200.00%-4K
-270.00%-68K
-140.00%-4K
Income before tax
26.34%-21.88M
-27.22%-22.68M
-3.76%-22.28M
-49.98%-89.97M
-35.26%-20.97M
-76.77%-29.71M
-28.01%-17.82M
-56.11%-21.47M
-20.82%-59.99M
-12.24%-15.5M
Income tax
6.90%62K
-15.28%61K
61.67%97K
-33.24%239K
-84.59%49K
346.15%58K
1,100.00%72K
185.71%60K
-29.53%358K
-26.90%318K
Net income
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
Net income continuous Operations
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
Minority interest income
Net income attributable to the parent company
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.28%-21.95M
-27.05%-22.74M
-3.93%-22.37M
-49.49%-90.21M
-32.85%-21.02M
-76.97%-29.77M
-28.47%-17.9M
-56.31%-21.53M
-20.31%-60.35M
-11.05%-15.82M
Basic earnings per share
33.33%-0.28
-24.00%-0.31
3.23%-0.3
23.95%-1.27
0.00%-0.29
4.55%-0.42
54.55%-0.25
43.64%-0.31
24.43%-1.67
48.21%-0.29
Diluted earnings per share
33.33%-0.28
-24.00%-0.31
3.23%-0.3
23.95%-1.27
0.00%-0.29
4.55%-0.42
54.55%-0.25
43.64%-0.31
24.43%-1.67
48.21%-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -24.85%24.94M20.69%25.54M5.34%25.45M65.34%102.56M42.96%24.06M91.90%33.18M50.23%21.16M74.73%24.16M21.96%62.03M13.11%16.83M
Selling and administrative expenses -46.77%9.77M2.53%7.19M-3.41%6.86M74.29%39.06M6.95%6.6M257.69%18.35M29.25%7.01M24.82%7.1M14.65%22.41M13.92%6.17M
-General and administrative expense -46.77%9.77M2.53%7.19M-3.41%6.86M74.29%39.06M6.95%6.6M257.69%18.35M29.25%7.01M24.82%7.1M14.65%22.41M13.92%6.17M
Research and development costs 2.28%15.17M29.69%18.35M8.98%18.59M60.28%63.5M63.81%17.46M21.96%14.83M63.37%14.15M109.64%17.06M26.53%39.62M12.64%10.66M
Operating profit 24.85%-24.94M-20.69%-25.54M-5.34%-25.45M-65.34%-102.56M-42.96%-24.06M-91.90%-33.18M-50.23%-21.16M-74.73%-24.16M-24.41%-62.03M-21.26%-16.83M
Net non-operating interest income expense -11.26%3.09M-15.29%2.88M18.16%3.18M511.42%12.9M150.98%3.33M597.39%3.48M1,486.45%3.4M3,802.90%2.69M1,141.18%2.11M2,314.55%1.33M
Non-operating interest income -11.26%3.09M-15.29%2.88M18.16%3.18M511.42%12.9M150.98%3.33M597.39%3.48M1,486.45%3.4M3,802.90%2.69M1,141.18%2.11M2,314.55%1.33M
Other net income (expense) -540.00%-32K76.67%-14K-200.00%-12K-361.76%-314K-6,025.00%-245K64.29%-5K-11.11%-60K-200.00%-4K-270.00%-68K-140.00%-4K
Other non- operating income (expenses) -540.00%-32K76.67%-14K-200.00%-12K-361.76%-314K-6,025.00%-245K64.29%-5K-11.11%-60K-200.00%-4K-270.00%-68K-140.00%-4K
Income before tax 26.34%-21.88M-27.22%-22.68M-3.76%-22.28M-49.98%-89.97M-35.26%-20.97M-76.77%-29.71M-28.01%-17.82M-56.11%-21.47M-20.82%-59.99M-12.24%-15.5M
Income tax 6.90%62K-15.28%61K61.67%97K-33.24%239K-84.59%49K346.15%58K1,100.00%72K185.71%60K-29.53%358K-26.90%318K
Net income 26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M
Net income continuous Operations 26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M
Minority interest income
Net income attributable to the parent company 26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.28%-21.95M-27.05%-22.74M-3.93%-22.37M-49.49%-90.21M-32.85%-21.02M-76.97%-29.77M-28.47%-17.9M-56.31%-21.53M-20.31%-60.35M-11.05%-15.82M
Basic earnings per share 33.33%-0.28-24.00%-0.313.23%-0.323.95%-1.270.00%-0.294.55%-0.4254.55%-0.2543.64%-0.3124.43%-1.6748.21%-0.29
Diluted earnings per share 33.33%-0.28-24.00%-0.313.23%-0.323.95%-1.270.00%-0.294.55%-0.4254.55%-0.2543.64%-0.3124.43%-1.6748.21%-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data